| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |